An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
Synonyms
Hydroxycarbamidum
N-Carbamoylhydroxylamine
Hydrea
Hydroxyurea
Hydroxycarbamide
Carbamyl hydroxamate
Hydroxyharnstoff
N-Hydroxyurea
Oxyurea
Carbamohydroximic acid
Carbamohydroxamic acid
Hidroxicarbamida
Carbamoyl oxime
Hydroxycarbamid
Brand Names
Droxia
Hydroxyurea
Hydrea
Siklos
Xromi
Apo-hydroxyurea
Riva-hydroxyurea
Mylan-hydroxyurea
Indication
Hydroxyurea is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises.[L41150]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682